The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
7
item.page.dc.date.issued
2022-01-01
item.page.dc.type
item.page.dc.identifier.eissn
11791500
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-85125207398
item.page.oaire.citation.title
Open Access Emergency Medicine
item.page.oaire.citation.volume
14
item.page.oaire.citation.startPage
51
item.page.oaire.citation.endPage
61
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Open Access Emergency Medicine Vol.14 (2022) , 51-61
punsarn.item.page.citation
Sricharoen P., Chueluecha C., Yuksen C., Jenpanitpong C. The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients. Open Access Emergency Medicine Vol.14 (2022) , 51-61. 61. doi:10.2147/OAEM.S345308 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/86660
item.page.dc.title
The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
item.page.dc.contributor.author
item.page.oairecerif.author.affiliation
item.page.dc.contributor.other
item.page.dc.description.abstract
Background: Sepsis causes high mortality in vulnerable groups such as hematologic malignancy (HM) patients. There are various early warning scores of sepsis, eg, qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS). This study aimed to compare REWS, qSOFA, and SOFA in predicting severe complications in hematologic malignancy patients visiting ED. Methods: The study was conducted as a retrospective cohort study at the ED of Ramathibodi Hospital, Bangkok, Thailand. Adult HM patients suspected of sepsis and have visited ED between March 2016 and December 2019. Results: Among 124 patients in our cohort, 51 (41%) had serious complication in ED and 20 (16%) died within 28 days after admission. The AUROCs of SOFA and qSOFA indicate significantly higher predicting in serious complication in ED than REWS (SOFA, 0.81 [95% CI, 0.73–0.89], qSOFA, 0.73 [95% CI, 0.65–0.81], REWS, 0.62 [95% CI, 0.52–0.72] p=0.004) while the predicting in 28-day mortality is not statistically significantly different (SOFA, 0.73 [95% CI, 0.60–0.85], qSOFA, 0.69 [95% CI, 0.58–0.80], REWS, 0.60 [95% CI, 0.44–0.75] p=0.25). Conclusion: The SOFA score is highest in predicting severe complications among hematologic malignancy patients.